PARP (Poly [ADP-Ribose] Polymerase) is a 113-kDa nuclear chromatin-associated enzyme that catalyzes the transfer of ADP-ribose units from NAD+ to a variety of nuclear proteins including topoisomerases, histones, and PARP itself.The catalytic activity of PARP is increased in cells following DNA damage, and PARP is thought to play an important role in mediating the normal cellular response to DNA damage.Additionally, PARP is a target of the caspase protease activity associated with apoptosis.The PARP protein consists of an N-terminal DNA-binding domain (DBD) and a C-terminal catalytic domain separated by a central automodification domain.During apoptosis, Caspase-3 cleaves PARP at a recognition site (Asp Glu Val Asp Gly) in the DBD to form 24- and 89-kDa fragments.This process separates the DBD (which is mostly in the 24-kDa fragment) from the catalytic domain (in the 89-kDa fragment) of the enzyme, resulting in the loss of normal PARP function.It has been proposed that inactivation of PARP directs DNA-damaged cells to undergo apoptosis rather than necrotic degradation, and the presence of the 89-kDa PARP cleavage fraction is considered to be a marker of apoptosis.
A peptide corresponding to the N-terminus of the cleavage site (Asp 214) of human PARP was used as the immunogen. The F21-852 monoclonal antibody reacts only with the 89-kDa fragment of human PARP-1 that is downstream of the Caspase-3 cleavage site (Asp214) and contains the automodification and catalytic domains.It does not react with intact human PARP-1.Cross-reactivity with other members of the PARP superfamily is unknown.Recognition of cleaved PARP in mouse cells has been demonstrated, and it may also cross-react with a number of other species due to the conserved nature of the molecule.
Alexa Fluor® 647 conjugates are highly photostable and remain fluorescent over a broad pH range. The excitation and emission maxima are nearly identical to those of APC. However, APC tends to be brighter while Alexa Fluor® 647 is more optimal for intracellular applications. This fluorochrome exhibits uncommon photostability, making it an ideal choice for use in fluorescence microscopy. Due to nearly identical excitation and emission properties but different spillover characteristics, APC and Alexa Fluor® 647 cannot be used simultaneously.
Perm/Wash Buffer RUO 100mLCat No: 554723
Perm Buffer III RUO 125mLCat No: 558050
Fixation/Permeabilization Solution Kit RUO 250Cat No: 554714
Hoechst 33342 Solution RUO 1mgCat No: 561908
Fixation and Permeabilization Solution RUO 125mLCat No: 554722
Resources & Tools | ||||||
---|---|---|---|---|---|---|
Spectrum Viewer | Panel Designer | SpectrumViewer | Download TDS | Regulatory Document Website |
Store undiluted at 4°C and protected from prolonged exposure to light.Do not freeze.The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.The antibody was conjugated to Alexa Fluor® 647 under optimum conditions, and unreacted Alexa Fluor® 647 was removed.
For Bioimaging
·Staurosporine (from Streptomyces staurosporeus) is a relatively non-selective protein kinase inhibitor that is often used as a general agent for inducing apoptosis. A stock solution of 2 μM staurosporine should be prepared in culture medium before use.
·This antibody stains HeLa (ATCC CCL-2), A549 (ATCC CCL-185) and U-2 OS (ATCC HTB-96) cells, and it works with either 90% cold methanol or BD Perm/Wash™ buffer permeabilization.
1. Seed the cells in appropriate culture medium at ~10,000 cells per well in a BD Falcon™ 96-well Imaging Plate (Cat. No. 353219), and culture overnight.
2. Add the appropriate concentrations of staurosporine, diluted in 100 μl of culture medium, to the wells and culture for 4 hours.
3. Fix the cells by adding 100 µl of a pre-warmed (37°C) 12% formaldehyde solution to each well and incubating for 30 minutes at room temperature (RT).The final volume is 300 μl per well with a 4% formaldehyde final concentration.
4. Remove the fixative from the wells, and wash the cells twice with 1× PBS.
5. Permeabilize the cells using either -20°C 90% cold methanol (eg. BD Phosflow™ Perm Buffer III, Cat. No. 558050) or BD Perm/Wash™ buffer
(Cat. No. 554723):
a.Add 100 µl of -20°C 90% methanol, BD Phosflow™ Perm Buffer III (Cat. No. 558050), to each well and incubate for 5 minutes.
or b.Add 100 µl of 1× BD Perm/Wash™ buffer to each well and incubate for 30 minutes at RT.
6.Remove the permeabilizer, and wash the wells twice with 100 μl of 1× PBS.
7. Dilute the Alexa Fluor® 647 Mouse anti-Cleaved PARP (Asp 214) antibody conjugate:
a.If the cells were permeabilized with cold methanol, dilute the antibody 1:10 in 1× PBS
or b.If the cells were permeabilized with BD Perm/Wash™ buffer, dilute the antibody 1:10 in 1× BD Perm/Wash™ buffer.
8. Stain the cells by adding 50 µl of the diluted antibody conjugate to each well and incubating for 1 hour at RT or overnight at 4°C, protected
from light.
9. Remove the diluted antibody conjugate, and wash the wells twice with 100 μl of 1X PBS. Remove the PBS.
10. To counter-stain the nuclei, dilute Hoechst 33342 Solution (Cat. No. 561908) to 2 μg/ml in 1× PBS, and add 200 μl to each well at least 15 minutes before imaging.
11.View and analyze the cells on an appropriate imaging instrument.Recommended filters for the BD Pathway™ instruments are:
InstrumentExcitationEmissionDichroic
BD Pathway 855620/60700/75660 LP
BD Pathway 435628/40690/40FF660
For flow cytometry
·Camptothecin, an extract of the Chinese tree Camptotheca acuminata, has been reported to induce apoptosis in a dose-dependent manner in vitro. A stock solution of 1.0 mM camptothecin (eg, Sigma-Aldrich; Cat. No. C-9911) should be prepared in DMSO before use.
1.Add camptothecin at 4-6 µM final concentration per 1 x 10^6 proliferating Jurkat cells (Human T-cell leukemia; ATCC TIB-152). A control aliquot of untreated cells should also be prepared. Incubate the cells for 4 - 18 hours in a 37°C incubator.
2.Wash the cells twice with cold PBS, resuspend them in BD Cytofix/Cytoperm™ solution at 2 x 10^6 cells/ml, and incubate for 20 minutes on ice.
3.Pellet the cells, and aspirate and discard the BD Cytofix/Cytoperm™ solution.
4.Wash the cells twice at room temperature with 0.5 ml BD Perm/Wash™ buffer per 1 x 10^6 cells, and discard the supernatants.
5.Resuspend the cells in BD Perm/Wash™ buffer at 10 x 10^6cells/ml, and aliquot test samples of 1 x 10^6 cells per 100-µl test.
6.Add 5 µl Alexa Fluor® 647 Mouse Anti-Cleaved PARP (Asp 214) antibody per test, and incubate for 30 minutes at room temperature, protected from light.
7.Wash each test in 1.0 ml BD Perm/Wash™ Buffer and discard the supernatant.
8.Resuspend each test in 0.5 ml BD Perm/Wash™ Buffer and analyze by flow cytometry.
BD是世界上最大的生产和销售医疗设备、医疗系统和试剂的医疗技术公司之一。致力于提高全世界人类的健康水平。BD专注于改进药物治疗,提高传染性疾病诊断的质量和速度,推进新型药物和疫苗的研究与发现。公司于1897年在纽约成立,总部位于美国新泽西州的富兰克林湖,业务可分为BD医疗、BD诊断、BD生物科学三大类,生产销售包括医用耗材、实验室仪器、抗体、试剂、诊断等产品。